Ikarian-Capital

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "EWTX",
  "TRVI",
  "NKTR",
  "INSM",
  "FBRX",
  "TGTX",
  "APLS",
  "ALNY",
  "ARCT",
  "DNA",
  "SWTX",
  "RCKT",
  "SGMO",
  "ARVN",
  "ALT",
  "RCUS",
  "OLMA",
  "GPCR",
  "RLAY",
  "THRD",
  "TERN",
  "TRML",
  "NUVB",
  "TYRA",
  "MNMD",
  "TECX",
  "LRMR",
  "MLYS",
  "KYMR",
  "NMRA",
  "ABEO",
  "KROS",
  "GLUE",
  "PRTA",
  "ABOS",
  "ANRO",
  "ALEC",
  "ALLK",
  "AVTX",
  "JANX",
  "ANEB",
  "PHGE",
  null,
  "GERN",
  "SRRK",
  "FULC",
  "APGE",
  "TARS",
  "TKNO",
  "INBX",
  "JSPR",
  "MGNX",
  "LXEO",
  "LYEL",
  null,
  "MNPR",
  null,
  "STIM",
  "OKUR",
  "PYXS",
  "RLMD",
  "SGMT",
  "SNSE",
  "SYBX",
  "CYBN",
  null,
  "AEMD",
  "TOVX",
  "RZLT",
  "ACRS",
  "ACOG",
  "INCY",
  "TEVA",
  "SPY",
  "PTGX",
  "PEPG",
  "TRAW",
  "RNA",
  "SLDB",
  "PRAX",
  "LXRX",
  "LYRA",
  "MLTX",
  "IBIO",
  "EVAX",
  "SLNO",
  "ACLX",
  "QURE",
  "RNAC",
  "ETNB",
  "DYN",
  "SPRB",
  "SRPT",
  "CHRO",
  null,
  null,
  "CRVS",
  "CDTX",
  "ELDN",
  "ELEV",
  "ELVN",
  "DCTH",
  "EOLS",
  "IMUX",
  "HROW",
  "HOOK",
  "ITOS",
  "KPTI",
  "KOD",
  "KZR",
  "VRNA",
  "VERU",
  "VTYX",
  "VERV",
  "VTGN",
  "VKTX",
  "VIR",
  "VIGL",
  "VRDN",
  "VYGR",
  "ORKA",
  "BHVN",
  "TRUP",
  "TDOC",
  "RARE",
  "IMVT",
  "PCVX",
  "BPMC",
  "BBIO",
  "CAPR",
  "CELC",
  "CPRX",
  "CLDX",
  "CMPX",
  "CORT",
  "CRNX",
  "CPIX",
  "CYTK",
  "IRON",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 141
Total Value: 710178588
Accession Number: 0001420506-25-001276
Form Type: 13F-HR
CIK: ikarian-capital
Manager Name: Ikarian-Capital

Data Enrichment

96% identified

135 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

141 positions • $710.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 8

Sort by:

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:494.9K

Value:$6.7M

% of Portfolio:0.9% ($6.7M/$710.2M)

INSMED Inc

INSM|457669307

Shares:84.8K

Value:$6.5M

% of Portfolio:0.9% ($6.5M/$710.2M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:280.0K

Value:$6.2M

% of Portfolio:0.9% ($6.2M/$710.2M)

CATALYST PHARMACEUTICALS, INC.

CPRX|14888U101

Shares:249.6K

Value:$6.1M

% of Portfolio:0.9% ($6.1M/$710.2M)

CYTOKINETICS INC

CYTK|23282W605

Shares:150.0K

Value:$6.0M

% of Portfolio:0.8% ($6.0M/$710.2M)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:289.5K

Value:$5.7M

% of Portfolio:0.8% ($5.7M/$710.2M)

Praxis Precision Medicines, Inc.

PRAX|74006W207

Shares:145.5K

Value:$5.5M

% of Portfolio:0.8% ($5.5M/$710.2M)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:248.9K

Value:$5.4M

% of Portfolio:0.8% ($5.4M/$710.2M)

Alpha Cognition Inc.

ACOG|02074J501

Shares:967.9K

Value:$5.1M

% of Portfolio:0.7% ($5.1M/$710.2M)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:100.0K

Value:$4.8M

% of Portfolio:0.7% ($4.8M/$710.2M)

Tectonic Therapeutic, Inc.

TECX|878972108

Shares:269.1K

Value:$4.8M

% of Portfolio:0.7% ($4.8M/$710.2M)

Forte Biosciences, Inc.

FBRX|34962G208

Shares:609.2K

Value:$4.7M

% of Portfolio:0.7% ($4.7M/$710.2M)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:264.1K

Value:$4.6M

% of Portfolio:0.6% ($4.6M/$710.2M)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

Shares:113.1K

Value:$4.1M

% of Portfolio:0.6% ($4.1M/$710.2M)

59267L107

Shares:150.0K

Value:$4.1M

% of Portfolio:0.6% ($4.1M/$710.2M)

Neuronetics, Inc.

STIM|64131A105

Shares:1.1M

Value:$4.0M

% of Portfolio:0.6% ($4.0M/$710.2M)

CAPRICOR THERAPEUTICS, INC.

CAPR|14070B309

Shares:400.0K

Value:$3.8M

% of Portfolio:0.5% ($3.8M/$710.2M)

MoonLake Immunotherapeutics

MLTX|61559X104

Shares:94.5K

Value:$3.7M

% of Portfolio:0.5% ($3.7M/$710.2M)

INCYTE CORP

INCY|45337C102

Shares:60.4K

Value:$3.7M

% of Portfolio:0.5% ($3.7M/$710.2M)

Viking Therapeutics, Inc.

VKTX|92686J106

Shares:150.0K

Value:$3.6M

% of Portfolio:0.5% ($3.6M/$710.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	494.9K	QoQ +5.31% (-25.0K) YoY +176.66% (+316.0K)	All Managers (Combined)	$6.7M	0.9% ($6.7M/$710.2M)	QoQ -25.94% (-$2.3M) YoY +112.98% (+$3.5M)
INSMED Inc(INSMcusip457669307)	84.8K	QoQ -29.21% (-35.0K) YoY -75.57% (-262.4K)	All Managers (Combined)	$6.5M	0.9% ($6.5M/$710.2M)	QoQ -21.78% (-$1.8M) YoY -31.31% (-$3.0M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	280.0K	QoQ +139900.00% (+279.8K) YoY NEW(+280.0K)	All Managers (Combined)	$6.2M	0.9% ($6.2M/$710.2M)	QoQ +115255.80% (+$6.2M) YoY NEW(+$6.2M)
CATALYST PHARMACEUTICALS, INC.(CPRXcusip14888U101)	249.6K	QoQ -28.60% (-100.0K) YoY -51.84% (-268.7K)	All Managers (Combined)	$6.1M	0.9% ($6.1M/$710.2M)	QoQ -17.03% (-$1.2M) YoY -26.73% (-$2.2M)
CYTOKINETICS INC(CYTKcusip23282W605)	150.0K	QoQ 0.00% (-0) YoY +49.98% (-50.0K)	All Managers (Combined)	$6.0M	0.8% ($6.0M/$710.2M)	QoQ -14.56% (-$1.0M) YoY -14.02% (-$983.2K)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	289.5K	QoQ -26.61% (-105.0K) YoY NEW(+289.5K)	All Managers (Combined)	$5.7M	0.8% ($5.7M/$710.2M)	QoQ -35.81% (-$3.2M) YoY NEW(+$5.7M)
Praxis Precision Medicines, Inc.(PRAXcusip74006W207)	145.5K	QoQ NEW(+145.5K) YoY +567.44% (+123.7K)	All Managers (Combined)	$5.5M	0.8% ($5.5M/$710.2M)	QoQ NEW(+$5.5M) YoY +314.22% (+$4.2M)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	248.9K	QoQ +361.51% (+195.0K) YoY NEW(+248.9K)	All Managers (Combined)	$5.4M	0.8% ($5.4M/$710.2M)	QoQ +269.82% (+$3.9M) YoY NEW(+$5.4M)
Alpha Cognition Inc.(ACOGcusip02074J501)	967.9K	QoQ +28.04% (+212.0K) YoY NEW(+967.9K)	All Managers (Combined)	$5.1M	0.7% ($5.1M/$710.2M)	QoQ +14.78% (+$658.3K) YoY NEW(+$5.1M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	100.0K	QoQ +42.85% (+30.0K) YoY NEW(+100.0K)	All Managers (Combined)	$4.8M	0.7% ($4.8M/$710.2M)	QoQ +78.97% (+$2.1M) YoY NEW(+$4.8M)
Tectonic Therapeutic, Inc.(TECXcusip878972108)	269.1K	QoQ +89.06% (-126.8K) YoY NEW(+269.1K)	All Managers (Combined)	$4.8M	0.7% ($4.8M/$710.2M)	QoQ -27.47% (-$1.8M) YoY NEW(+$4.8M)
Forte Biosciences, Inc.(FBRXcusip34962G208)	609.2K	QoQ 0.00% (-0) YoY NEW(+609.2K)	All Managers (Combined)	$4.7M	0.7% ($4.7M/$710.2M)	QoQ -65.83% (-$9.1M) YoY NEW(+$4.7M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	264.1K	QoQ -7.04% (-20.0K) YoY +13104.25% (+262.1K)	All Managers (Combined)	$4.6M	0.6% ($4.6M/$710.2M)	QoQ -40.66% (-$3.1M) YoY +5232.84% (+$4.5M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	113.1K	QoQ -36.81% (-65.9K) YoY NEW(+113.1K)	All Managers (Combined)	$4.1M	0.6% ($4.1M/$710.2M)	QoQ -45.61% (-$3.4M) YoY NEW(+$4.1M)
(cusip59267L107)✕	150.0K	QoQ NEW(+150.0K) YoY NEW(+150.0K)	All Managers (Combined)	$4.1M	0.6% ($4.1M/$710.2M)	QoQ NEW(+$4.1M) YoY NEW(+$4.1M)
Neuronetics, Inc.(STIMcusip64131A105)	1.1M	QoQ NEW(+1.1M) YoY NEW(+1.1M)	All Managers (Combined)	$4.0M	0.6% ($4.0M/$710.2M)	QoQ NEW(+$4.0M) YoY NEW(+$4.0M)
CAPRICOR THERAPEUTICS, INC.(CAPRcusip14070B309)	400.0K	QoQ +10.77% (-38.9K) YoY NEW(+400.0K)	All Managers (Combined)	$3.8M	0.5% ($3.8M/$710.2M)	QoQ -23.82% (-$1.2M) YoY NEW(+$3.8M)
MoonLake Immunotherapeutics(MLTXcusip61559X104)	94.5K	QoQ NEW(+94.5K) YoY -40.18% (-63.5K)	All Managers (Combined)	$3.7M	0.5% ($3.7M/$710.2M)	QoQ NEW(+$3.7M) YoY -53.47% (-$4.2M)
INCYTE CORP(INCYcusip45337C102)	60.4K	QoQ NEW(+60.4K) YoY NEW(+60.4K)	All Managers (Combined)	$3.7M	0.5% ($3.7M/$710.2M)	QoQ NEW(+$3.7M) YoY NEW(+$3.7M)
Viking Therapeutics, Inc.(VKTXcusip92686J106)	150.0K	QoQ NEW(+150.0K) YoY -25.00% (-50.0K)	All Managers (Combined)	$3.6M	0.5% ($3.6M/$710.2M)	QoQ NEW(+$3.6M) YoY -77.91% (-$12.8M)